156 related articles for article (PubMed ID: 2997262)
21. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A
J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451
[TBL] [Abstract][Full Text] [Related]
22. Haemodynamic and renal effects of urodilatin in healthy volunteers.
Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
Eur J Clin Invest; 1992 May; 22(5):319-25. PubMed ID: 1317296
[TBL] [Abstract][Full Text] [Related]
23. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans.
Kanno K; Hirata Y; Emori T; Ohta K; Eguchi S; Imai T; Marumo F
Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):619-25. PubMed ID: 1327594
[TBL] [Abstract][Full Text] [Related]
24. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
25. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
[TBL] [Abstract][Full Text] [Related]
26. Effect of native and synthetic atrial natriuretic factor on cyclic GMP.
Hamet P; Tremblay J; Pang SC; Garcia R; Thibault G; Gutkowska J; Cantin M; Genest J
Biochem Biophys Res Commun; 1984 Sep; 123(2):515-27. PubMed ID: 6091631
[TBL] [Abstract][Full Text] [Related]
27. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
[TBL] [Abstract][Full Text] [Related]
28. Cellular mechanisms of action of atrial natriuretic factor.
Gerzer R; Heim JM; Schütte B; Weil J
Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
[TBL] [Abstract][Full Text] [Related]
29. [Changes in plasma atrial natriuretic factor, plasma and urinary cyclic GMP during exercise in coronary patients and healthy subjects].
Baudouy PY; Abassade P; Longueville G; Bastien P; Besse F; Valleteau de Moulliac M; Michel JB
Arch Mal Coeur Vaiss; 1993 Apr; 86(4):479-87. PubMed ID: 8239876
[TBL] [Abstract][Full Text] [Related]
30. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
Jespersen B; Jensen L; Sørensen SS; Pedersen EB
Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
[TBL] [Abstract][Full Text] [Related]
31. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
[TBL] [Abstract][Full Text] [Related]
32. Effects of a bolus dose of atrial natriuretic factor in young and elderly volunteers.
Heim JM; Gottmann K; Weil J; Strom TM; Gerzer R
Eur J Clin Invest; 1989 Jun; 19(3):265-71. PubMed ID: 2553423
[TBL] [Abstract][Full Text] [Related]
33. Atrial natriuretic factors (ANF) and antidiuretic agents.
Croxatto HR; Rosas R
Acta Physiol Pharmacol Latinoam; 1988; 38(1):1-9. PubMed ID: 2974232
[TBL] [Abstract][Full Text] [Related]
34. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
35. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
36. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
37. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
Scott JM; Barclay PL; Shepperson NB
Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941
[TBL] [Abstract][Full Text] [Related]
38. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
Wilkins MR; Settle SL; Needleman P
J Clin Invest; 1990 Apr; 85(4):1274-9. PubMed ID: 2156897
[TBL] [Abstract][Full Text] [Related]
39. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
40. The dihydropyridine calcium channel blocker BAY t 7207 attenuates the exercise induced increase in plasma ANF and cyclic GMP in patients with mildly impaired left ventricular function.
Kentsch M; Otter W; Drummer C; Peinke V; Theisen K; Müller-Esch G; Gerzer R
Eur J Clin Pharmacol; 1995; 49(3):177-82. PubMed ID: 8665993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
